BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6322710)

  • 1. Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients.
    Jones PG; Kauffman CA; McAuliffe LS; Liepman MK; Bergman AG
    Arch Intern Med; 1984 Mar; 144(3):549-51. PubMed ID: 6322710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.
    Vogler WR; Malcom LG; Winton EF
    Cancer Invest; 1987; 5(4):267-73. PubMed ID: 3664330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment.
    Shepp DH; Klosterman A; Siegel MS; Meyers JD
    J Infect Dis; 1985 Dec; 152(6):1257-63. PubMed ID: 3905986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients.
    Thunnissen PL; Sizoo W; Hendriks WD
    Neth J Med; 1991 Aug; 39(1-2):84-91. PubMed ID: 1660108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of mycosis in granulocytopenic patients. A comparative study between nystatin and ketoconazole.
    Avilés A; Ambríz R; Escobedo J; Sinco A; Pizzuto J; Macotela E
    Arch Invest Med (Mex); 1984; 15(1):55-65. PubMed ID: 6089686
    [No Abstract]   [Full Text] [Related]  

  • 6. Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: correlation of colonization and clinical outcome.
    Buchanan AG; Riben PD; Rayner EN; Parker SE; Ronald AR; Louie TJ
    Clin Invest Med; 1985; 8(2):139-47. PubMed ID: 3879598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoconazole versus nystatin as prophylaxis against fungal infection for lymphoma patients receiving chemotherapy.
    Turhan A; Connors JM; Klimo P
    Am J Clin Oncol; 1987 Aug; 10(4):355-9. PubMed ID: 2441593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of mycotic infections in immunocompromised patients: a review of 27 reports and publications.
    Cauwenbergh G
    Drugs Exp Clin Res; 1986; 12(5):419-27. PubMed ID: 3522162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of systemic candidiasis in neutropenic dogs with ketoconazole.
    Weber MJ; Keppen M; Gawith KE; Epstein RB
    Exp Hematol; 1985 Sep; 13(8):791-5. PubMed ID: 3899697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin for infection prophylaxis in granulocytopenic patients with acute leukemia.
    Cortellaro M; Cofrancesco E; Pasargiklian I; Bianchi R; Pozzoli E; Annaloro C; Ranzi ML; Mascheroni E; Polli N
    Haematologica; 1990; 75(6):541-5. PubMed ID: 2098296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketoconazole: clinical evaluation in severe fungal infections.
    Lechi A; Montesi G; Dean P; Pancera P; Arosio E
    Chemioterapia; 1986 Feb; 5(1):18-22. PubMed ID: 3955777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of fungal infections in neutropenic cancer patients.
    Meunier-Carpentier F
    Schweiz Med Wochenschr Suppl; 1983; 14():15-9. PubMed ID: 6318307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Burgaleta C
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketoconazole for prevention of fungal infections in neutropenic leukemia patients.
    Capnist G; Chisesi T; Dini E; Vaglia A; Piacentini I
    Haematologica; 1987; 72(2):185. PubMed ID: 3114079
    [No Abstract]   [Full Text] [Related]  

  • 16. Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study.
    Hansen RM; Reinerio N; Sohnle PG; Abrams RA; Ritch PS; Libnoch JA; Anderson T
    Arch Intern Med; 1987 Apr; 147(4):710-2. PubMed ID: 3548626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prophylactic ketoconazole and nystatin on fungal flora.
    Kauffman CA; Jones PG; Bergman AG; McAuliffe LS; Liepman MK
    Mykosen; 1984 Apr; 27(4):165-72. PubMed ID: 6328295
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized trial of oral vancomycin in neutropenic patients.
    Guyotat D; Plonton C; Fiere D
    Prog Clin Biol Res; 1985; 181():263-5. PubMed ID: 3895236
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):861-72. PubMed ID: 2865921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
    Isaacs D
    Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.